Worrying rise in chronic lung disease in women over past decade

August 20, 2000

Recent trends in physician diagnosed COPD in women and men in the UK 2000; 55: 789-94

The rates of chronic lung disease (COPD) in women have almost doubled over the past decade, shows research published in Thorax.

Rates of COPD were audited from data fed into the General Practice Research Database. This contains continuing information on around 4 million patients throughout England and Wales supplied by over 500 general practices.

COPD is a general term to describe chronically obstructed airflow in the delicate airways of the lungs. Some of it is attributable to ageing and the natural decline in lung function, but most of it is caused by the effects of smoking.The symptoms cannot be cured, merely alleviated. Around 3 million people die of it each year, and worldwide, it ranks fifth as the most common cause of death.

From the beginning of January 1990 to the end of 1997, almost half of the 50,000 new cases diagnosed were in women. The yearly prevalence of COPD in women almost doubled from 0.80 per cent to 1.36 per cent over the seven years of the study, reaching the rate observed for men in 1990. There was a substantial increase in rates of COPD in women aged 65 and older; rates in 45 to 65 year old women were equivalent to those in older men by 1996; and the rates in young women under 45 exceeded those of men in the mid-1990s. In men the rate peaked in the mid 1990s.

Patients with severe COPD died an average of three years before those with mild COPD and four years before they would be expected to do so. Women with COPD tended to survive longer than men, irrespective of the severity of their disease.

The authors conclude that the full effects of smoking trends in women have yet to be seen, as evidenced by the steady rise in lung cancer. And they suggest that COPD rates in women will continue to rise.
-end-
Contacts:

Dr John Soriano, or Dr Will Maier, Department of Worldwide Epidemiology, Glaxo-Wellcome Research and Development, London. jbs42397@glaxowellcome.co.uk




BMJ Specialty Journals

Related COPD Articles from Brightsurf:

Promising therapeutic approach against COPD
Chronic obstructive pulmonary disease (COPD) is one of the most common and deadliest diseases worldwide.

COPD underdiagnosed in older adults, but can be managed
''Recognizing and Treating COPD in Older Adults'' the latest issue of the What's Hot newsletter from The Gerontological Society of America, addresses what is known about the prevalence, incidence, and impact of chronic obstructive pulmonary disease (COPD) in older adults.

Undersized airways may explain why nonsmokers get COPD
A mismatch between airway and lung size may explain why some nonsmokers get COPD and some heavy smokers do not, according to a new study from Columbia University Irving Medical Center.

Is pulmonary rehab after hospitalization for COPD associated with better survival?
Claims data for nearly 200,000 Medicare patients were used to examine the association between starting pulmonary rehabilitation within 90 days of being hospitalized for chronic obstructive pulmonary disease (COPD) and survival after one year.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

COPD as a lung stem cell disease
Two internationally renowned stem cell researchers at the University of Houston have found an abundance of abnormal stem cells in the lungs of patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), a leading cause of death worldwide.

New hope for COPD patients possible with in-home device
In a new paper published Feb. 4 in JAMA, Mayo Clinic researchers describe the benefits of in-home noninvasive ventilation therapy, which includes a type referred to as bilevel positive airway pressure, or BiPAP -- for many patients with chronic obstructive pulmonary disease (COPD).

COPD appears to cause more severe symptoms in women
Women who develop COPD report smoking fewer cigarettes than men; and yet, women experience greater breathing impairments, are subjected to more acute exacerbations of symptoms and report lower quality of life than men with the disease, according to research presented at ATS 2019.

African-Americans with COPD appear less likely to use pulmonary rehab
African-American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby.

COPD and type 2 diabetes
COPD and type 2 diabetes are two highly prevalent global health conditions associated with high mortality and morbidity.

Read More: COPD News and COPD Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.